Skip to main content

Table 1 Description of compliance, recurrence and mortality among cases

From: Role of interleukin-6 in ischemic stroke outcome

 

No

% (N)

Yes

% (N)

Compliance

2.3% (2)

97.7% (88)

Recurrence

83.3% (75)

16.7% (15)

Mortality

88.9% (80)

11.1 %(10)